UTMD Utah Medical Products PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: UTMD
- PE Ratio
As of Nov 5, 2025, the Utah Medical Products stock's PE ratio is 15.51. This results from the current EPS of $3.74 and stock price of $58. The current PE ratio is nearly equal to the average from the previous four quarters.
UTMD PE ratio history
The PE ratio of Utah Medical Products has averaged 22.32 over the last ten years. The current PE ratio of 15.51 is 31% below the historical average. Over the past ten years, UTMD's PE ratio was at its highest in the Jun 2018 quarter at 43.37, when the stock price was $110.15 and the EPS was $2.54. The lowest value was in the Mar 2025 quarter, when it reached 14.83 with a price of $56.04 and an EPS of $3.78.
Utah Medical Products PE ratio by year
Maximum annual increase: 62.98% in 2019
Maximum annual decrease: -52.97% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 15.52 | -15.61% | $61.47 | $3.96 |
| 2023 | 18.39 | -17.12% | $84.22 | $4.58 |
| 2022 | 22.19 | -10.13% | $100.53 | $4.53 |
| 2021 | 24.69 | -13.61% | $100 | $4.05 |
| 2020 | 28.58 | 4.88% | $84.3 | $2.95 |
| 2019 | 27.25 | 62.98% | $107.9 | $3.96 |
| 2018 | 16.72 | -52.97% | $83.08 | $4.97 |
| 2017 | 35.55 | 57.86% | $81.4 | $2.29 |
| 2016 | 22.52 | 21.53% | $72.75 | $3.23 |
| 2015 | 18.53 | -6.18% | $58.54 | $3.16 |
| 2014 | 19.75 | 5.73% | $60.05 | $3.04 |
| 2013 | 18.68 | 43.58% | $57.16 | $3.06 |
| 2012 | 13.01 | -1.74% | $36.05 | $2.77 |
| 2011 | 13.24 | -18.22% | $27 | $2.04 |
| 2010 | 16.19 | -4.48% | $26.88 | $1.66 |
Utah Medical Products PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 15.22 | 2.63% | $56.92 | $3.74 |
| Mar 2025 | 14.83 | -4.45% | $56.04 | $3.78 |
| Dec 2024 | 15.52 | -0.96% | $61.47 | $3.96 |
| Sep 2024 | 15.67 | 1.56% | $66.91 | $4.27 |
| Jun 2024 | 15.43 | -2.16% | $66.81 | $4.33 |
| Mar 2024 | 15.77 | -14.25% | $71.11 | $4.51 |
| Dec 2023 | 18.39 | -0.33% | $84.22 | $4.58 |
| Sep 2023 | 18.45 | -5.77% | $86 | $4.66 |
| Jun 2023 | 19.58 | -2.3% | $93.2 | $4.76 |
| Mar 2023 | 20.04 | -9.69% | $94.77 | $4.73 |
| Dec 2022 | 22.19 | 14.74% | $100.53 | $4.53 |
| Sep 2022 | 19.34 | -1.38% | $85.31 | $4.41 |
| Jun 2022 | 19.61 | -8.58% | $85.9 | $4.38 |
| Mar 2022 | 21.45 | -13.12% | $89.86 | $4.19 |
| Dec 2021 | 24.69 | 2.41% | $100 | $4.05 |
UTMD Price vs fair value
UTMD average PE ratio chart
The current PE ratio of UTMD is below the 3, 5 and 10-year averages.
PE comparison
With a P/E of 15.51, UTMD is below the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 25.01, Utah Medical Products's P/E is 38% lower.
UTMD PE vs peers
UTMD's PE ratio is lower than its peer stocks JNJ and COO, but it is greater than CNMD's. Utah Medical Products is presently trading at a lower PE ratio (15.51) than its peer group average of 27.24.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 12.42 | $1.37B |
| UTMD Utah Medical Products Inc | 15.48 | $185.55M |
| JNJ Johnson & Johnson | 17.93 | $450.47B |
| TFX Teleflex Inc | 25.06 | $4.8B |
| COO Cooper Companies Inc | 33.82 | $13.72B |
| MMSI Merit Medical Systems Inc | 43.04 | $5.13B |
Frequently asked questions
What is Utah Medical Products's PE ratio?
The price to earnings ratio for UTMD stock is 15.51 as of Nov 5, 2025.
What is the 3-year average PE ratio for Utah Medical Products (UTMD)?
As an average over the last 3 years, UTMD stock has a PE ratio of 17.37.
What is the 5-year average PE ratio for Utah Medical Products (UTMD)?
As an average over the last 5 years, UTMD stock has a PE ratio of 20.14.
What is the highest PE ratio for UTMD?
The highest quarterly PE ratio in the last ten years has been 43.37 and it was in the Jun 2018 quarter.
How does the current PE ratio for UTMD compare to its historical average?
UTMD's price to earnings ratio is currently 31% below its 10-year historical average.
How is UTMD's PE ratio calculated (Utah Medical Products PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Nov 5, 2025), Utah Medical Products's stock price is $58. The earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $3.74. Therefore, Utah Medical Products's P/E ratio for today is 15.51. PE RATIO(15.51) = STOCK PRICE($58) / TTM EPS($3.74)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.